Jacksonville, FL, United States of America

Mingqi Bai

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Morris Plains, NJ (US) (2019 - 2021)
  • Jacksonville, FL (US) (2019 - 2024)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Mingqi Bai

Introduction

Mingqi Bai, an accomplished inventor based in Jacksonville, FL, has made significant contributions to the field of ocular treatments. With a remarkable portfolio of 16 patents, his work is at the forefront of innovations aimed at improving eye health and function.

Latest Patents

Two of Mingqi Bai's latest patents demonstrate his commitment to advancing treatments for eye conditions. The first patent introduces innovative compositions and methods for treating the eye, focusing on formulations that include extracts and compounds exhibiting retinol-like activity. These compositions are designed to enhance the treatment of various ocular ailments. The second patent also centers on eye treatment, presenting compositions that promote the production and delivery of hyaluronic acid and mucin within the cornea, thereby improving eye health.

Career Highlights

Throughout his career, Mingqi Bai has held significant positions at notable companies, including Johnson & Johnson Surgical Vision, Inc. and Johnson & Johnson Consumer Inc. His experiences in these organizations have allowed him to leverage his inventive skills and research capabilities to develop groundbreaking solutions in eye care.

Collaborations

Mingqi has worked alongside talented professionals in the industry, including Kenneth T Holeva and Wen-Hwa Ting Li. These collaborations have fostered an environment of innovation and creativity, further enhancing the impact of his contributions to ocular health.

Conclusion

Mingqi Bai stands out as a pioneering inventor whose work is shaping the future of eye treatment. With his impressive portfolio and collaborations, he continues to drive innovation in the field, promising better solutions for those affected by eye conditions. His dedication to research and development will undoubtedly leave a lasting impact on ocular health advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…